Viewing Study NCT06804603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-01-01 @ 5:58 AM
Study NCT ID: NCT06804603
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2025-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Sponsor: Vanda Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GLP-1R agonist View
None semaglutide View
None obesity View
None nausea View
None vomiting View